纽约市COVID-19暴发期间超额死亡的初步估计(2020年3月11日至5月2日)
本研究基于纽约市电子生命登记系统,通过匹配实验室确诊COVID-19病例,统计了2020年3月11日至5月2日期间实验室确诊和可能COVID-19相关死亡数,并探讨了全因超额死亡的估计方法。报告指出仅统计确诊和可能COVID-19死亡可能低估大流行影响,超额死亡(高于季节性基线水平的死亡数)可作为衡量大流行严重程度的非特异性指标。
要点
- 截至2020年5月2日,纽约市记录实验室确诊COVID-19相关死亡13,831例,可能相关死亡5,048例。
- 仅统计确诊和可能COVID-19死亡可能低估大流行归因死亡数,因未涵盖未检测、假阴性、院外死亡等情形。
- 全因超额死亡指高于预期季节性基线水平的死亡数,不限于报告死因,可更准确衡量大流行影响。
核心结论
- 仅统计实验室确诊和可能COVID-19相关死亡可能低估大流行实际造成的死亡负担,全因超额死亡是评估大流行影响的更全面指标。
研究设计与样本
- 基于纽约市电子生命登记系统(eVital)的死亡数据,与实验室确诊SARS-CoV-2感染病例每日匹配,统计2020年3月11日至5月2日期间确诊和可能COVID-19相关死亡,并描述超额死亡估计方法。
主要发现
- 截至2020年5月2日,纽约市共记录实验室确诊COVID-19相关死亡13,831例,可能COVID-19相关死亡5,048例。
关键数值与推荐
- 实验室确诊COVID-19相关死亡定义为实验室确诊SARS-CoV-2感染者的死亡;可能COVID-19相关死亡定义为死亡证明上将COVID-19、SARS-CoV-2或等效术语列为直接、根本或促进死因但无实验室确诊的死亡。
- 超额死亡定义为高于预期季节性基线水平的死亡数,不论报告死因。
临床怎么用
- 在公共卫生监测中,除确诊和可能COVID-19死亡外,应利用全因超额死亡指标评估大流行严重程度和实际影响。
局限性
- 确诊和可能COVID-19死亡计数可能遗漏未接受检测、检测假阴性、检测阴性后感染、院外死亡或医疗提供者未怀疑COVID-19的死亡;也不包括非直接关联SARS-CoV-2感染的死亡。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), was first identified in December 2019 in Wuhan, China, and has since spread worldwide. On March 11, 2020, the World Health Organization declared COVID-19 a pandemic (1). That same day, the first confirmed COVID-19-associated fatality occurred in New York City (NYC). To identify confirmed COVID-19-associated deaths, defined as those occurring in persons with laboratory-confirmed SARS-CoV-2 infection, on March 13, 2020, the New York City Department of Health and Mental Hygiene (DOHMH) initiated a daily match between all deaths reported to the DOHMH electronic vital registry system (eVital) (2) and laboratory-confirmed cases of COVID-19. Deaths for which COVID-19, SARS-CoV-2, or an equivalent term is listed on the death certificate as an immediate, underlying, or contributing cause of death, but that do not have laboratory-confirmation of COVID-19 are classified as probable COVID-19-associated deaths. As of May 2, a total of 13,831 laboratory-confirmed COVID-19-associated deaths, and 5,048 probable COVID-19-associated deaths were recorded in NYC (3). Counting only confirmed or probable COVID-19-associated deaths, however, likely underestimates the number of deaths attributable to the pandemic. The counting of confirmed and probable COVID-19-associated deaths might not include deaths among persons with SARS-CoV-2 infection who did not access diagnostic testing, tested falsely negative, or became infected after testing negative, died outside of a health care setting, or for whom COVID-19 was not suspected by a health care provider as a cause of death. The counting of confirmed and probable COVID-19-associated deaths also does not include deaths that are not directly associated with SARS-CoV-2 infection. The objective of this report is to provide an estimate of all-cause excess deaths that have occurred in NYC in the setting of widespread community transmission of SARS-CoV-2. Excess deaths refer to the number of deaths above expected seasonal baseline levels, regardless of the reported cause of death. Estimation of all-cause excess deaths is used as a nonspecific measure of the severity or impact of pandemics (4) and public health emergencies (5). Reporting of excess deaths might provide a more accurate measure of the impact of the pandemic.
引用
- Preliminary Estimate of Excess Mortality During the COVID-19 Outbreak - New York City, March 11-May 2, 2020. MMWR Morb Mortal Wkly Rep. 2020. PMID: 32407306. doi:10.15585/mmwr.mm6919e5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。